- Home
- TSBK vs PRQR Comparison
TSBK vs PRQR Comparison
Compare TSBK & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TSBK | PRQR |
|---|---|---|
| Founded | 1915 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.5M | 250.7M |
| IPO Year | 1998 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TSBK | PRQR |
|---|---|---|
| Price | $37.74 | $2.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $8.14 |
| AVG Volume (30 Days) | 17.1K | ★ 591.4K |
| Earning Date | 01-26-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.00% | N/A |
| EPS Growth | ★ 21.93 | N/A |
| EPS | ★ 3.67 | N/A |
| Revenue | ★ $81,618,000.00 | $18,859,556.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.20 | ★ N/A |
| Revenue Growth | ★ 10.07 | N/A |
| 52 Week Low | $27.51 | $1.07 |
| 52 Week High | $38.08 | $3.10 |
Technical Indicators
Market Signals| Indicator | TSBK | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 75.71 | 44.60 |
| Support Level | $36.99 | $2.15 |
| Resistance Level | $37.90 | $2.49 |
| Average True Range (ATR) | 0.77 | 0.18 |
| MACD | 0.25 | 0.01 |
| Stochastic Oscillator | 99.64 | 33.91 |
Price Performance
Historical ComparisonAbout TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company. It has one reportable operating segment which is defined as community banking in western Washington under the operating name Timberland Bank. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. It also offers loans to real estate, including residential and commercial, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.